Literature DB >> 7798658

Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis.

L Rasmussen1, S Morris, D Zipeto, J Fessel, R Wolitz, A Dowling, T C Merigan.   

Abstract

Human cytomegalovirus (CMV) DNA copy number in white blood cells from both human immunodeficiency virus (HIV)-seronegative and HIV-seropositive patients was amplified from the immediate-early region of CMV DNA and quantified by colorimetric detection of the hybridization of the amplification product to a detector oligonucleotide probe in microtiter wells. By Mann-Whitney U test, significantly higher (P < .05, two-tailed) copy numbers of CMV DNA were detected in HIV-seropositive patients with retinitis than in either patients with < 100 CD4 cells/mm3 and no symptomatic CMV disease or HIV-seropositive patients with > 100 CD4 cells/mm3. By prospective monitoring for increases in CMV DNA copy number, it may be possible to identify HIV-seropositive patients who are at imminent risk for development of symptomatic CMV retinitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798658     DOI: 10.1093/infdis/171.1.177

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence.

Authors:  R Boom; C Sol; J Weel; Y Gerrits; M de Boer; P Wertheim-van Dillen
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.

Authors:  B S Blank; P L Meenhorst; J W Mulder; G J Weverling; H Putter; W Pauw; W C van Dijk; P Smits; S Lie-A-Ling; P Reiss; J M Lange
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.

Authors:  G Boivin; J Handfield; E Toma; G Murray; R Lalonde; V J Tevere; R Sun; M G Bergeron
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.

Authors:  S Varani; P Spezzacatena; R Manfredi; F Chiodo; A Mastroianni; P Ballarini; A Boschini; T Lazzarotto; M P Landini
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

5.  Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.

Authors:  G J van den Horn; C Meenken; S A Danner; P Reiss; M D de Smet
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

6.  Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization.

Authors:  G E Buck
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

7.  Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System.

Authors:  G Boivin; J Handfield; G Murray; E Toma; R Lalonde; J G Lazar; M G Bergeron
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

8.  Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients.

Authors:  G M Gallez-Hawkins; B R Tegtmeier; A ter Veer; J C Niland; S J Forman; J A Zaia
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 9.  Management of CMV retinitis in HIV infected patients.

Authors:  C Katlama
Journal:  Genitourin Med       Date:  1997-06

10.  Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.

Authors:  W Y Barrett-Muir; C Aitken; K Templeton; M Raftery; S M Kelsey; J Breuer
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.